1-3 of 3
Jonathan Abbas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A first-in-human study of stx-0712, a CCR2+ cytotoxicity targeting chimera (CyTAC™) in patients with chronic myelomonocytic leukemia (CMML) and Acute Myeloid Leukemia (AML)

Free
Guillermo Montalban-Bravo, Courtney DiNardo, Peter Greenberg, Richard Stone, Eric Padron, David Sallman, Curtis Lachowiez, Jonathan Abbas, Abhishek Mangaonkar, Mrinal Patnaik, Marissa Timothy, Alonzo Martinez, Ewelina Morawa, Brandon Turunen, Philip Vickers, Sergio Santillana
Journal: Blood
Blood (2025) 146 (Supplement 1): 3874.
https://doi.org/10.1182/blood-2025-3874
Published: 2025
Journal Articles

Preliminary experience from the ODYSSEY trial: Efficacy and safety of momelotinib in combination with luspatercept in patients with transfusion-dependent myelofibrosis

Free
Prithviraj Bose, Jean-Christophe Ianotto, Regina Garcia-Delgado, Jonathan Abbas, Jasmine Sahni, Dwaipayan Patnaik, Catherine Ellis, Sunny Kim, Vikas Gupta
Journal: Blood
Blood (2025) 146 (Supplement 1): 3803.
https://doi.org/10.1182/blood-2025-3803
Published: 2025
Journal Articles

Real-World Treatment Experience of Venetoclax in Combination with Hypomethylating Agents in Patients with Newly Diagnosed Acute Myeloid Leukemia: Updated Experience from a Predominately Community Setting in the US

Free
Pankit Vachhani, Esprit Ma, Tao Xu, Melissa Montez, Sarah Worth, Wei-Han Cheng, Michael Werner, Jonathan Abbas, William Donnellan
Journal: Blood
Blood (2022) 140 (Supplement 1): 683–684.
https://doi.org/10.1182/blood-2022-157509
Published: 2022